U.S. markets closed

Vanda Pharmaceuticals Inc. (VNDA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.6100+0.1400 (+3.13%)
At close: 04:00PM EST
4.6500 +0.04 (+0.87%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close4.4700
Bid4.5700 x 2900
Ask4.6500 x 3000
Day's Range4.4700 - 4.7150
52 Week Range3.3000 - 7.0000
Avg. Volume984,124
Market Cap265.248M
Beta (5Y Monthly)0.68
PE Ratio (TTM)115.25
EPS (TTM)0.0400
Earnings DateMay 01, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-40% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for VNDA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Vanda Pharmaceuticals Inc.
    VNDA: Rating decreased to a SELLVANDA PHARMACEUTICALS INC has an Investment Rating of SELL; a target price of $5.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    6 months agoArgus Research
View more